Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid.
- DOI
- 10.1007/s13760-023-02215-z
- Published
- 2023 Aug
- Container
- Acta neurologica Belgica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13760-023-02215-z,
title = {Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid.},
author = {Lorenzoni PJ and Giugno VR and Ducci RD and Werneck LC and Kay CSK and Scola RH},
year = {2023},
journal = {Acta neurologica Belgica},
doi = {10.1007/s13760-023-02215-z},
url = {https://doi.org/10.1007/s13760-023-02215-z}
}RIS
TY - JOUR TI - Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid. AU - Lorenzoni PJ AU - Giugno VR AU - Ducci RD AU - Werneck LC AU - Kay CSK AU - Scola RH PY - 2023 JO - Acta neurologica Belgica DO - 10.1007/s13760-023-02215-z UR - https://doi.org/10.1007/s13760-023-02215-z ER -
APA
PJ, L., VR, G., RD, D., LC, W., CSK, K., & RH, S. (2023). Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid.. Acta neurologica Belgica. https://doi.org/10.1007/s13760-023-02215-z
Source records
- pubmed · retrieved 2026-11-10T16:33:12.204Z